Imosphere selected for EHDEN’s SME training and certification

Imosphere has been selected by the European Health Data & Evidence Network (EHDEN) to support its project to harmonise 100 million anonymised health records from across Europe to the Observational Medical Outcomes Partnership (OMOP) common data model (CDM).

EHDEN is an Innovative Medicines Initiative 2 (IMI2) consortium, bringing together 22 partners from across 12 countries to develop a federated network, standardized to a CDM, the OMOP format. Their vision is to create a trusted, observational ecosystem to enable better health decisions, outcomes and care.

To help achieve this, the consortium has developed a training programme for SMEs to become certified in mapping health data from various formats to the OMOP CDM.

Imosphere is one of the first five SMEs to be part of the initial wave of training which begins in August 2019. Post certification and the awarding of grants, Imosphere will then progress to working with Data Partners to perform local mappings, helping to build the network.

Toby Rogers, CTO of Imosphere, said, “We’re proud to have been selected to receive training in the OMOP CDM. Being one of the first SMEs in Europe to do so is a great opportunity to contribute to the use of open standards in healthcare.

“It’s rewarding to see our global experience in managing large-scale, healthcare data using the OMOP CDM, recognised by the consortium. We’re looking forward to playing a significant role in helping to establish a thriving community that’s focused on improving healthcare research and better outcomes of patients throughout Europe.”

For the latest updates, please visit the EHDEN website.

Download the press release.

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 806968. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.